World's Best Scientists 2026 revealed!
Martti Färkkilä

Martti Färkkilä

D-Index & Metrics

Medicine

D-Index
87
Citations
31056
World Ranking
13556
National Ranking
152

Overview

Martti Färkkilä is affiliated with the University of Helsinki in Finland and has contributed extensively to the field of medicine, with a specific focus on surgery, hepatology, epidemiology, pulmonary and respiratory medicine, and genetics.

Their research encompasses a broad range of topics including:

  • Liver Diseases and Immunity
  • Liver Disease Diagnosis and Treatment
  • Gallbladder and Bile Duct Disorders
  • Esophageal Cancer Research and Treatment
  • Liver Disease and Transplantation
  • Esophageal and GI Pathology
  • Cholangiocarcinoma and Gallbladder Cancer Studies

Martti Färkkilä has published in several frequent venues such as:

  • Journal of Hepatology
  • Gastrointestinal Endoscopy
  • Nature
  • Nature Communications
  • Scandinavian Journal of Gastroenterology

Recent papers associated with or relevant to their work include:

  • The mutational constraint spectrum quantified from variation in 141,456 humans, 2020, Nature
  • FinnGen provides genetic insights from a well-phenotyped isolated population, 2023, Nature
  • A genomic mutational constraint map using variation in 76,156 human genomes, 2023, Nature
  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study, 2022, The Lancet. Gastroenterology & Hepatology
  • FinnGen: Unique genetic insights from combining isolated population and national health register data, 2022, bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors collaborating with Martti Färkkilä include:

  • Fredrik Åberg
  • Giola Santoni
  • Jesper Lagergren
  • Joonas H. Kauppila
  • My von Euler-Chelpin

Best Publications

  • A structural variation reference for medical and population genetics

    Ryan L Collins;Ryan L Collins;Harrison Brand;Harrison Brand;Konrad J Karczewski;Konrad J Karczewski;Xuefang Zhao;Xuefang Zhao

  • Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

    David Laharie;Arnaud Bourreille;Julien Branche;Matthieu Allez

  • Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings

    Taina Sipponen;Erkki Savilahti;Kaija-Leena Kolho;Hannu Nuutinen

  • Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers.

    Nina Mars;Jukka T Koskela;Pietari Ripatti;Tuomo T J Kiiskinen

  • Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

    Michael P. Manns;Marek Woynarowski;Wolfgang Kreisel;Yoav Lurie

  • A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.

    Kajander K;Hatakka K;Poussa T;Färkkilä M

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.

    Taina Sipponen;P Kärkkäinen;Erkki Savilahti;Kaija-Leena Kolho

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Celiac disease in patients with severe liver disease: Gluten-free diet may reverse hepatic failure

    Katri Kaukinen;Leena Halme;Pekka Collin;Martti Färkkilä

  • Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora

    J Kuisma;S Mentula;H Jarvinen;A Kahri

  • Family and twin studies in inflammatory bowel disease

    Leena Halme;Paulina Paavola-Sakki;Ulla Turunen;Maarit Lappalainen

  • CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease

    T Heliö;L Halme;M Lappalainen;H Fodstad

  • Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

    Sun Gou Ji;Brian D. Juran;Sören Mucha;Trine Folseraas

  • Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti‐TNF‐alpha therapy for Crohn's disease

    Taina Sipponen;Erkki Savilahti;Päivi Kärkkäinen;Kaija-Leena Kolho

  • Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    Homie Razavi;Sarah Robbins;Stefan Zeuzem;Francesco Negro

  • Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: A three‐year randomized trial

    Henna Rautiainen;Päivi Kärkkäinen;A-L Karvonen;Heimo Nurmi

  • Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study

    Ulla M. Turunen;Martti A. Färkkilä;Kalle Hakala;Kari Seppälä

  • Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.

    Lars Aabakken;Tomh. Karlsen;Joerg Albert;Marianna Arvanitakis

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Pentti Sipponen
Pentti Sipponen University of Helsinki
Kimmo Kontula
Kimmo Kontula University of Helsinki
Kirsten Muri Boberg
Kirsten Muri Boberg University of Oslo
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Nina Langeland
Nina Langeland Haukeland University Hospital
Veikko Salomaa
Veikko Salomaa Finnish Institute for Health and Welfare
Gunnar Norkrans
Gunnar Norkrans University of Gothenburg
Cyriel Y. Ponsioen
Cyriel Y. Ponsioen University of Amsterdam
Tatu A. Miettinen
Tatu A. Miettinen University of Helsinki
Tom H. Karlsen
Tom H. Karlsen Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering medicine in the USA, various online degrees and alternative career pathways can provide flexibility and specialization. An accelerated lpn program offers a quick route to entering the nursing field, allowing you to start your healthcare journey sooner while balancing other commitments.

For those with a greater interest in mental health, online msn pmhnp programs prepare you for advanced practice roles as a psychiatric-mental health nurse practitioner. These programs offer the flexibility to continue working while advancing your credentials and expertise.

Alternatively, if your interests lie in healthcare leadership or administration, a healthcare administration degree online is a cost-effective way to gain managerial skills relevant to hospitals, clinics, or public health organizations. Those seeking to further their administrative education can consider the cheapest online mha programs for an affordable master's degree in healthcare administration.

These online options create flexible and affordable pathways into the healthcare sector, accommodating a variety of interests and career goals beyond traditional medical school.

Best Scientists Citing Martti Färkkilä

Trending Scientists

Recently Published Articles